Cell Therapy Development and Manufacturing - NeoStem
NeoStem, Inc. is an international biopharmaceutical company with adult stem cell operations in the U.S., a network of adult stem cell therapeutic providers in China as well as a 51% ownership interest in a profitable Chinese generic pharmaceutical manufacturing company. NeoStem is focused on accelerating the development of proprietary cellular therapies and becoming a single source for collection, storage, manufacturing, therapeutic development and transportation of cells for cell based medic...
Reviewed on Apr 21st, 2013


Featured at embed code
-
Press about neostem.com
-
neostem.com writes about
-

-
pharmiweb.com Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction - News Press Release | PharmiWeb.com
Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction PR NewswireNEW YORK, Jan. 25, 2012NEW YORK, Jan. 25, 2012 /PRNewswire/ -- Amorcyte, LLC, a NeoStem, Inc. company (NYSE Amex: NBS)( Read article
-
churchinhistory.org The Vatican's Council Starts Collaboration with $1M Undertaking|
For more information, please visit: http://www.neostem.com . This initiative will partner NeoStem's and the Vatican's charitable organizations to expand research and raise awareness of adult stem cell therapies. The initiative will entail work on a variety of collaborative activities with the goa... Read article
-
lifesciencesworld.com Breakthrough: The Pontifical Council for Culture and NeoStem Partner to Advance Adult Stem Cell Research | LifeSciencesWorld
For more information, please visit: http://www.neostem.com . “Providing critical support to drive research and therapy efforts, this commitment is a milestone for the field of regenerative medicine,” added Dr. Smith. As part of the collaboration, NeoStem and the Pontifical Council will pursue th... Read article
-
skynewswire.com SkyNewswire.com - NeoStem Spotlights Projected Multibillion-Dollar Adult Stem Cell Therapeutics Market in Latest Investor Video - Contemporary Cult...
Its stem cell collection systems will be located in physician offices and medical facilities, where the procedures and care can be administered by trusted personal doctors and medical professionals. For more information, please visit: www.neostem.com . For other information and resources about th... Read article
-
redorbit.com NeoStem Announces the Addition of Joseph Talamo as Vice President, Corporate Controller and Chief Accounting Officer - Health News - redOrbit
Furthermore, NeoStem is building its Chinese presence by establishing an operations lab for cell-based manufacturing in Beijing as well as commercializing cellular therapies in China through the establishment of a network of hospitals. NeoStem also owns a majority-interest in Suzhou Erye Pharmace... Read article
-
walb.com Texas Gulf Energy, Inc. to be Featured at National Investment Banking Association Conference in NYC June 7-8 - WALB.com, Albany News, Weather, Sports
We could not be happier being the first company to present, kicking off an exciting two days of presentations by several other great companies." Other presentations slated for the NIBA conference at Le Parker Meridien Hotel in Midtown Manhattan include NeoStem, Inc. ( www.neostem.com ), Equities.... Read article
-
newyork.citybizlist.com NeoStem Appoints Jonathan Sackner-Bernstein as Vice President - Citybizlist New York
Athelos Corporation ("Athelos"), which is approximately 80%-owned by our subsidiary, PCT, is engaged in collaboration with Becton-Dickinson that is exploring the earlier stage clinical development of a T-cell therapy for autoimmune conditions. In addition, our pre-clinical assets include our VSEL... Read article
-
ca.finance.yahoo.com NeoStem Announces the Addition of Jonathan Sackner-Bernstein, MD, Past FDA Official, as Vice President, Clinical Development and Regulatory Affairs...
The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control. Contact: Phone: +1-646-378-2949 Email: gogawa@troutgroup.com NeoStem, Inc. Phone: +1-212-584-4174 Email: rsmith@neostem.com Related Headlines On T... Read article
-
linkedin.com Jane Youdelman | LinkedIn
Location Industry See who you and Jane Youdelman know in common Get introduced to Jane Youdelman Contact Jane Youdelman directly Past Connections Stem Cell Collection Coordinator October 2008 – January 2011 (2 years 4 months) visit www.neostem.com See who you and Jane Youdelman know in common Get... Read article
-
asianetnews.net AsiaNet - View Release
For more information, please visit: http://www.neostem.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of th... Read article
-
appliedclinicaltrialsonline.com Amorcyte, a NeoStem Company, Announces Expansion of Intellectual Property Coverage - Applied Clinical Trials
Go→ Amorcyte, a NeoStem Company, Announces Expansion of Intellectual Property Coverage Publish date: Jan 10, 2012 PR Newswire NEW YORK, Jan. 10, 2012 NEW YORK, Jan. 10, 2012 /PRNewswire/ -- Amorcyte, Inc. ("Amorcyte"), a NeoStem, Inc. company (NYSE Amex: NBS) ("NeoStem" or the "Company"), today a... Read article
-
lead411.com Robin Smith | NeoStem | Email CEO @neostem.com CFO
NeoStem Salary Information 0 CEO Reference: Robin Smith - Located in New York, NY NeoStem Inc has Robin Smith serving as the organization's CEO/Chairman. Robin Smith is NeoStem Inc's CEO. Need Robin Smith's email, linkedin, facebook and biography? You can find those in NeoStem Inc Lead411 profile... Read article
-
tradershuddle.com Progenitor Cell Therapy, a Subsidiary of NeoStem, Continues to Develop its Client Base | PRNewswire - TradersHuddle.com
Furthermore, NeoStem is building its Chinese presence by establishing an operations lab for cell-based manufacturing in Beijing as well as commercializing cellular therapies in China through the establishment of a network of hospitals. NeoStem also owns a majority-interest in Suzhou Erye Pharmac... Read article
-
philly.citybizlist.com NeoStem Acquires Progenitor Cell Therapy - Citybizlist Philadelphia
For more information, please visit: http://www.neostem.com . Robin Smith, MD, MBA, CEO of NeoStem said, "The merger with PCT is a significant step toward NeoStem's goal of becoming a leader in the fast-growing Stem Cell Industry, generating revenues, and developing and licensing therapies to be u... Read article
-
genengnews.com GEN | Industry Updates: NeoStem Announces Participation in Multiple September Conferences
Biotechnology from bench to business. Current Issue. Top Keywords. NeoStem Announces Participation in Multiple September Conferences. GEN webinars. GEN poll. Most popular. Subscription center. Add GEN to your Inbox FREE!. Enbrel Biosimilar. e-NEWSLETTERS. All fields are required. GEN MAGAZINE. Ne... Read article
Twitter about neostem.com
Facebook about neostem.com